Northwestern University Human Resources
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Improving Functioning in Peripheral Arterial Disease
- Conditions
- Cardiovascular DiseasesPeripheral Vascular Diseases
- Interventions
- Behavioral: ExerciseBehavioral: Diet
- First Posted Date
- 2005-03-23
- Last Posted Date
- 2012-07-25
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 156
- Registration Number
- NCT00106327
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-09-16
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004172
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
- Conditions
- Endometrial Cancer
- First Posted Date
- 2004-08-30
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004915
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-08-30
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004090
- Locations
- 🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
- Conditions
- Lymphoma
- First Posted Date
- 2004-08-23
- Last Posted Date
- 2012-05-30
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00002479
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-08-20
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004182
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004096
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
- Conditions
- Non-Hodgkin's Lymphoma (NHL)
- Interventions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 30
- Registration Number
- NCT00089284
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Jesse B. Brown Veterans Affairs Medical Center, Chicago, Illinois, United States
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease
- Conditions
- Lymphoma
- First Posted Date
- 2004-07-26
- Last Posted Date
- 2012-07-02
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004169
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
- Conditions
- Esophageal Cancer
- First Posted Date
- 2004-07-26
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00004897
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States